Chengdu Firster Pharmaceutical Technology Co., Ltd., established in September 2005, is located in the central city of Chengdu in western China. It is an international research enterprise that integrates research and development, production, and sales.
The company is mainly committed to the research, development, and production of raw materials and new pharmaceutical intermediates, forming a production capacity from small-scale, pilot to industrial scale. Every year, we will promote the development of hundreds of new pharmaceutical intermediates and intermediates for various new drug products to domestic and international markets. At the same time, we also conduct research and development, technology transfer, and technical services for new drug intermediates.
The company is composed of a professional team of highly qualified and experienced personnel, leading the company to continuously explore new pharmaceutical intermediates. At present, our company not only has a leading platform for new pharmaceutical intermediates and raw material technology, but also is equipped with advanced instruments and equipment, as well as complete and accurate analysis and detection methods.
Our company has completed the research and development, pilot testing, and production of over 2000 pharmaceutical intermediates and dozens of active pharmaceutical ingredients. Forming several major product systems - heterocyclic (piperidine series, pyrrolidine series, piperazine series, imidazole series, thiazole series, pyrimidine series, indole series, etc.) cyclohexylamine, boric acid series, phenylacetylene series, amino acid series, etc.
The company adheres to the principle of "casting quality, pursuing excellence" to provide customers and end users with high-quality products and comprehensive after-sales service.
The company is mainly committed to the research, development, and production of raw materials and new pharmaceutical intermediates, forming a production capacity from small-scale, pilot to industrial scale. Every year, we will promote the development of hundreds of new pharmaceutical intermediates and intermediates for various new drug products to domestic and international markets. At the same time, we also conduct research and development, technology transfer, and technical services for new drug intermediates.
The company is composed of a professional team of highly qualified and experienced personnel, leading the company to continuously explore new pharmaceutical intermediates. At present, our company not only has a leading platform for new pharmaceutical intermediates and raw material technology, but also is equipped with advanced instruments and equipment, as well as complete and accurate analysis and detection methods.
Our company has completed the research and development, pilot testing, and production of over 2000 pharmaceutical intermediates and dozens of active pharmaceutical ingredients. Forming several major product systems - heterocyclic (piperidine series, pyrrolidine series, piperazine series, imidazole series, thiazole series, pyrimidine series, indole series, etc.) cyclohexylamine, boric acid series, phenylacetylene series, amino acid series, etc.
The company adheres to the principle of "casting quality, pursuing excellence" to provide customers and end users with high-quality products and comprehensive after-sales service.
